Neuroleptic malignant syndrome (NMS) and tardive dyskinesia. 1987

A Jee

UI MeSH Term Description Entries
D009459 Neuroleptic Malignant Syndrome A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72) Neuroleptic-Induced Neuroleptic Malignant Syndrome,Neuroleptic-Malignant Syndrome, Neuroleptic Induced,NMS (Neuroleptic Malignant Syndrome),NMSs (Neuroleptic Malignant Syndrome),Neuroleptic Induced Neuroleptic Malignant Syndrome,Neuroleptic Malignant Syndrome, Neuroleptic Induced,Neuroleptic Malignant Syndromes,Syndrome, Neuroleptic Malignant,Syndromes, Neuroleptic Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Jee
January 1987, The British journal of psychiatry : the journal of mental science,
A Jee
August 2012, Nihon rinsho. Japanese journal of clinical medicine,
A Jee
December 2017, Asian journal of psychiatry,
A Jee
September 1990, Acta psychiatrica Scandinavica,
A Jee
December 1987, The British journal of psychiatry : the journal of mental science,
A Jee
May 1996, The American journal of psychiatry,
A Jee
January 1987, Acta psychiatrica Belgica,
A Jee
September 1981, Arizona medicine,
A Jee
September 1997, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!